|
||||||
| Home |
| Find a Clinical Trial |
| Clinical Trial FAQs |
| About Informed Consent |
| Clinical Trials Glossary |
| Medical Research Areas |
| Clinical Trial Resources |
|
 |
Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only. | |
|
|
 |
|
|
|
|||
|
Novartis Clinical
Trials provides information about research studies recruiting
within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S. |
|
|
Find a Clinical Trial
Kidney Transplantation
A kidney transplant is an operation that places a healthy kidney in the body. The transplanted kidney takes over the work of the two kidneys that failed, and dialysis is no longer needed. [Source: www.nlm.nih.gov/medlineplus]
Novartis is seeking people to participate in a clinical trial(s) testing the safety and effectiveness of Novartis products. Novartis recommends that you consult your doctor before participating in a clinical trial. For more information about clinical trial participation, click here. Also, for additional information about how Novartis helps to protect the privacy of the personal information that you provide to us, please see the Novartis Privacy Policy. Please review the details of the clinical trial(s) listed below and click on the one that you feel best suits your (or the participant's) condition.
Kidney Transplant Study - A2214
The purpose of this partially blinded, prospective, randomized, multi-center study is to evaluate the efficacy and safety of a Novartis investigational drug when combined with an existing therapy for the prevention of acute rejection after do novo renal transplantation. An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.
Trial phase: Phase 2 Participation Duration: Participation in this study includes coming to the doctor's office/clinic 21 times over 3 years. Each visit will take about 2 hours. Protocol Number: CAEB071A2214 Kidney Transplant - AUS92
The purpose this 12 month, multi-center, randomized, open-label non-inferiority study is to compare the safety and efficacy of a Novartis investigational drug with low doses of an existing therapy to another combination therapy in kidney transplant patients. An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.
Trial phase: Phase 3 Participation Duration: Participation in this study will last 12 months, and you will be asked to come to the doctor's office/clinic/study site for 15 visits. Protocol Number: CRAD001AUS92 |